Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The schistosome tegument is a specialized syncytial cytoplasmic layer that serves as the outer surface of Schistosoma parasites, acting as the primary interface with the host vascular environment (Skelly & Wilson, 2006, PubMed: 16722846). It is a highly dynamic structure bounded by a unique double-lipid bilayer, which is essential for nutrient uptake, osmoregulation, and protection against host immune and digestive mechanisms (Braschi & Wilson, 2006, PubMed: 16631105). The tegument plays a pivotal role in immune evasion by constantly renewing its surface and expressing proteins that modulate or mask the parasite from the host immune system (Moné et al., 2010, PubMed: 20847962). It is the principal target of the anthelmintic drug Praziquantel, which causes rapid calcium-dependent contraction and tegumental vacuolization, leading to the exposure of internal parasite antigens to host antibodies (Cioli et al., 2014, PubMed: 24507435). Due to its critical role in parasite survival and its direct exposure to the host bloodstream, the tegument is a primary focus for the development of both new schistosomicidal drugs and recombinant vaccines targeting surface proteins like SmTSP-2 (Hotez et al., 2010, PubMed: 20231882).
Induction of rapid calcium influx leading to tegumental vacuolization, surface blebbing, and exposure of parasite antigens to the host immune system (Cioli et al., 2014, PubMed: 24507435).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Schistosome tegument.